UBS Group »

Reviva Pharmaceu shares owned by UBS Group

Quarter-by-quarter ownership of Reviva Pharmaceu (RVPH) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Reviva Pharmaceu

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceu held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceu by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8k 5.3k 0.73

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Reviva Pharmaceu

Millennium Management
Jpmorgan Chase & Co
Armistice Capital
GSA Capital Partners
EMC Capital Management
Vanguard Capital Management
Warberg Asset Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Hrt Financial
Castleview Partners
Two Sigma Investments
Morgan Stanley
UBS Group

View all funds holding Reviva Pharmaceu